(Received for publication, October 13, 1995)
From the
Cytosine deaminase (EC 3.5.4.1), a non-mammalian enzyme, catalyzes the deamination of cytosine and 5-fluorocytosine to form uracil and 5-fluorouracil, respectively. Eukaryotic cells have been genetically modified with a bacterial cytosine deaminase gene to express a functional enzyme. When the genetically modified cells are combined with 5-fluorocytosine, it creates a potent negative selection system, which may have important applications in cancer gene therapy. In this paper, we introduce a novel positive selection method based upon the expression of the cytosine deaminase gene. This method utilizes inhibitors in the pyrimidine de novo synthesis pathway to create a condition in which cells are dependent on the conversion of pyrimidine supplements to uracil by cytosine deaminase. Thus, only cells expressing the cytosine deaminase gene can be rescued in a positive selection medium.
Bacterial cytosine deaminase (CDase) ()catalyzes the
deamination of cytosine to form uracil(1) . CDase can also
catalyze the deamination of 5-fluorocytosine (5-FC) to form
5-fluorouracil (5-FU), a widely used antitumor agent. Since CDase is
present in bacteria and fungi, but not present in mammalian cells, the
gene encoding CDase has been exploited in an enzyme/prodrug gene
therapy approach to cancer
treatment(2, 3, 4, 5) . As example,
for metastatic colorectal carcinoma, an artificial gene composed of the
carcinoembryonic antigen transcriptional regulatory domain has been
linked to the coding domain of the CDase gene(4, 6) .
When infused into the liver, CDase is expressed in the carcinoembryonic
antigen-positive metastatic tumor cells but not in the normal liver
cells. Metabolic conversion of the non-toxic prodrug, 5-FC, to the
potent antitumor anabolite, 5-FU, occurs selectively in the tumor
cells. Most importantly, it has been demonstrated that only a very
small percentage of tumor cells (2%-4%) in a tumor mass need express
CDase to achieve significant antitumor effect(5, 7) .
This significant ``bystander'' effect results from the fact
that 5-FU is produced at such high local concentrations (5) and
5-FU crosses biological membranes predominantly by non-facilitated
diffusion(8) .
The current challenge for the successful
clinical exploitation of this approach is to routinely achieve CDase
gene transfer at the required specific activity in a solid tumor mass.
We are currently comparing and contrasting different viral and
non-viral gene delivery systems. For ease in manipulation, titering,
and evaluation of gene transfer, a dominant selectable marker gene,
such as the neomycin resistance gene (Neo) is included with
the therapeutic CDase gene. Despite widespread practice, it has been
suggested that such a double gene system with neomycin
phosphotransferase may cause gene instability and potentially lower
viral titers(9, 10) . It may be very desirable to use
CDase as both a positive and negative selectable marker in a single
gene system.
CDase has a very narrow range of substrates(11) . There is no known toxic compound that can be directly detoxified by CDase for use in a positive selection scheme. As an alternative approach, we have attempted to make mammalian cells depend upon CDase activity by blocking de novo pyrimidine synthesis. Once blocked, these cells will then depend on the activity of CDase to convert extracellular cytosine into uracil for growth.
A de novo pyrimidine synthesis inhibitor, N-(phosphonacetyl)-L-aspartate (PALA), inhibits aspartate carbamyl transferase (Fig. 1) of the CADase complex(12, 13, 14) . This PALA-induced blockade induces apoptosis, and as such, is lethal to mammalian cells in culture(15) . However, the toxic effects of PALA can be completely circumvented by supplying uridine (15, 16, 17, 18) .
Figure 1:
The de novo pyrimidine synthesis pathway. De novo pyrimidine
synthesis pathway and the mechanism for the positive selection using
the CDase coupled with inosine and cytosine in the selection media to
rescue PALA-induced apoptosis. CADases, carbamyl synthase,
aspartate carbamyltransferase, and dihydroprotase; CDase,
cytosine deaminase; PNPase, purine nucleoside phosphorylase; UKase, uridine kinase; UPase, uridine phosphorylase; OMP, orotate monophosphate; PALA, N-(phosphonacetyl)-L-aspartate;
P, phosphate; R-1-P
,
ribose 1-phosphate; UMP, uridine
monophosphate.
We have explored the combination of PALA and CDase as a positive selection method for cells expressing CDase. We now present the formula for this CDase-positive selection scheme and provide data for the efficacy of this system. Such a system makes it possible to use the CDase gene as a positive selection marker gene.
All cells were grown in Dulbecco's modified essential medium supplemented with 2 mML-glutamine, 0.1 mM nonessential amino acids, and 5% dialyzed fetal calf serum (complete medium). Cell culture selection was carried out by supplementing the complete medium with either 1 mg/ml G418 for neomycin selection or combinations of PALA, inosine, and cytosine for the positive CDase selection. Cell morphology was monitored daily under the microscope.
The in vitro cytotoxicity of PALA on JM-1, JM-1/CD,
PA317, and PA317/CD cells was first determined (Fig. 2). PALA
was similarly toxic in all cell lines, with IC and
IC
being approximately 150 ± 20 µM and
1.00 ± 0.02 mM, respectively.
Figure 2:
In vitro cytotoxicity of PALA.
Cells were cultured for 7 days in complete media supplemented with
increasing amounts of PALA. Cytotoxicity was determined on days 0, 3,
5, and 7 as described under ``Experimental Procedures.'' Data
are represented as the percentage of cell growth in PALA-containing
media compared to the cell growth in complete medium without PALA.
, day 0;
, day 3;
, day 5;
, day
7.
PALA-induced cytotoxicity could not be reverted with cytosine alone (up to 5 mM), cytosine plus thymine (up to 2 mM each), cytidine (up to 2 mM), or cytidine and deoxycytidine (up to 2 mM each) in the CDase-positive cells.
In another approach, we synthesized orotate analogues 2-aminoorotate and 6-carboxycytosine. We hoped that CDase could convert these compounds into orotate so that the PALA inhibition on de novo pyrimidine synthesis could be bypassed (Fig. 1). However, supplementing the medium with these orotate analogues could not restore the growth of the CDase-positive cells. Subsequently, we have determined that neither 6-carboxycytosine or 2-aminoorotate are substrates for the bacterial CDase (data not shown).
However, PALA-induced toxicity could be reversed in CDase-positive cells if the culture media were supplemented with 20 mg/liter cytosine and 1-4 mM inosine (Fig. 3). In JM-1/CD, there was a 90% recovery when 4 mM inosine was present in the selection medium. In PA317/CD, approximately 80% recovery was obtained in 2 mM inosine containing medium. Thus, in the presence of inosine and cytosine in the medium, only CDase gene altered cells could overcome the toxic effects induced by PALA.
Figure 3:
Positive
selection of CDase-positive cells using cytosine, inosine, and PALA.
Cells were cultured in complete media supplemented with 1 mM PALA, 20 mg/liter cytosine, and increasing amounts of inosine.
Cell survival was determined on days 0, 3, and 5 as described under
``Experimental Procedures.'' Data are represented as the
percentage of cell growth in PALA-containing media compared to the cell
growth in complete medium. A, , JM-1 at day 0;
,
JM-1 at day 5;
, JM/CD at day 0;
, JM/CD at day 5. B,
, PA317 at day 0;
, PA317 at day 3;
,
PA317 at day 5;
, PA317/CD at day 0;
, PA317/CD at day 3;
, PA317/CD at day 5.
To
effectively use media supplemented with PALA, cytosine, and inosine
(selection medium) to positively select for cells that express CDase,
it is important that the uridine metabolite cannot significantly
diffuse out of the cells and subsequently rescue adjacent
CDase-negative cells. To assess this potential, PA317/CD and 3T3
TK cells were plated in 24-well Transwell(TM) AA
plates and grown in the selection medium. PA317/CD cells were plated
into the inserts, while an equal amount of 3T3 TK
cells were plated in the bottom wells. Metabolite diffusion was
assessed on days 4 and 7 using cell growth of the control cells as an
indicator (Fig. 4). Unmodified 3T3 TK
cells at
the bottom wells died, while modified PA317/CD cells in the inserts
grew.
Figure 4:
Metabolic diffusion assay. Cells were
cultured in complete media supplemented with 1 mM PALA, 1
mg/ml inosine, and increasing amounts of cytosine. PA317/CD cells were
plated in the inserts of the 24-well Transwell(TM) plates, while an
equal amount of 3T3 TK cells were plated in the
bottom wells. Cytotoxicity was determined at days 4 and 7 as described
under ``Experimental Procedures.'' Data are represented as
the percentage of cell growth in PALA-containing media compared to the
cell growth in complete medium without PALA.
, PA317/CD at day
4;
, PA317/CD at day 7;
, 3T3TK
at day
4;
, 3T3TK
at day
7.
Taken collectively, these data indicate that cytosine and inosine can rescue CDase-positive cells from the PALA-induced blockade in de novo pyrimidine synthesis. These data also showed that uridine or uracil, which was generated in the selection process, was insufficient to rescue CDase-negative cells.
Based on the above results, a positive selection medium was formulated by supplementing complete medium with 1 mM PALA, 1 mg/ml inosine, and 1 mM cytosine. This formulation was used in the following assays to validate its efficacy in the positive selection system.
Cell growth rates were compared in the positive selection medium and normal complete medium (Fig. 5). Unmodified parental cells did not grow in the positive selection medium. JM-1/CD grew similarly in either media, while PA317/CD grew relatively slower in the positive selection medium. This may result from the relative enzymatic activity of CDase in the two cell lines (approximately 50 nmol/min/mg in JM-1/CD and 17 nmol/min/mg in PA317/CD).
Figure 5:
Comparison of cell growth rates in either
complete or positive selection medium. Equal amount of cells were
seeded and cultured in either complete medium or the positive selection
medium (complete medium supplemented with 1 mM PALA, 1 mg/ml
inosine, 1 mM cytosine). Cell growth rate was determined as
described under Experimental Procedures. , complete/parental;
, complete/CD;
, selection/parental;
,
selection/CD.
In the positive selection medium, cells expressing CDase showed no obvious morphological changes up to 5 days (Fig. 6H) when compared with cells cultured in normal complete medium (Fig. 6, E and F). However, CDase-negative cells showed significant PALA toxicity by day 3 (Fig. 6C) and showed characteristics of apoptosis (swollen nucleus and dissegmentation) by day 5 (Fig. 6G). CDase-positive cells grew similarly in either complete or selection media (Fig. 7, B and D), while CDase-negative cells were dead in positive selection medium (Fig. 7, A and C).
Figure 6: Morphological characteristics of cells in either complete or positive selection medium. Equal amounts of PA317 (A, C, E, and G) and PA317/CD (B, D, F, and H) cells were seeded and cultured in either complete medium (A, B, E, and F) or positive selection medium (complete medium supplemented with 1 mM PALA, 1 mg/ml inosine, 1 mM cytosine). Cell morphological appearance was photographed at day 1 (A and B), day 3 (C and D), and day 5 (E, F, G, and H).
Figure 7: Cell cycle distribution in either complete or positive selection medium. PA317 (A and C) and PA317/CD (B and D) cells were cultured in either complete medium (A and B) or positive selection medium (C and D) for 7 days. After fixation in 70% ethanol, cell cycle distribution was determined by flow cytometry analysis as described under ``Experimental Procedures.''
Cell cycle
distribution studies confirmed that in the positive selection medium,
PA317 cells (CDase-negative) showed typical distribution of apoptotic
cells. However, PA317/CD cells (CDase-positive) were viable but showed
a delay at G/G
stages, with 50% reduction of
cells committing to either S or G
+ M stages (Table 1). This result was consistent with the observation that
PA317/CD grew slower in the positive selection medium compared to that
in the complete medium (Fig. 5B). However, there was no
significant apoptosis presented for CDase-positive cells in selection
medium.
Genetic manipulation of cells is an important tool in
molecular cell biology. There are numerous procedures for genetically
modifying cells and subsequently selecting for these modifications.
Positive selection is one of the most popular means, since it takes
advantage of the cells lacking certain detoxifying enzymes (i.e. Amp (ampicillin resistance), Tet
(tetracycline resistance), Kan
(kanamycin
resistance), Neo
(neomycin resistance), and Hyg
(hygromycin B resistance)). Another means is complementation
culture by providing certain enzymes to mutant cells deficient or weak
in certain essential enzymes (i.e. CADases, adenosine kinase,
and TK). Both strategies consist of one toxin, one detoxification
enzyme, or one complementation enzyme system. Such strategies do not
work with CDase since there is no toxic compound known to be
selectively detoxified by CDase.
To solve this problem, we have employed PALA to block the de novo synthesis pathway of pyrimidines and force the cells to rely on a CDase dependent salvage pathway (Fig. 1). Because of the narrow substrate range of CDase, cytidine, 2`-deoxycytidine, and the orotate analogs 6-carboxycytosine and 2-aminoorotate were not converted to useful anabolites by the enzyme. Although CDase effectively converts cytosine into uracil, the intrinsic equilibrium between uracil and uridine is clearly in favor of uracil. It became obvious that supplying cytosine alone would not allow for rescue of CDase-positive cells in the presence of PALA.
To circumvent the problem, the equilibrium between uracil and uridine had to be altered. To accomplish this goal, inosine was used to increase the cellular concentration of ribose 1-phosphate, thereby shifting the equilibrium between uracil and uridine toward uridine (Fig. 1). For JM-1/CD cells, the rescue of the CDase-positive cells by cytosine and inosine was approximately 100%. However, the rescue of the PA317/CD cells was approximately 80%. This may result from the intracellular enzymatic activity of the CDase.
Although growth recovery differs from cell line to cell line, CDase gene-modified cells grown in the positive selection medium do not undergo significant cell death. Their growth rates may slightly decreased depending on the enzymatic activity of CDase, but their morphological characters are not altered (Fig. 6).
In summary, the bacterial CDase gene can be used as a positive selection marker in combination with PALA, cytosine, and inosine in the positive selection medium. This positive selection is safe and effective in manipulating cells altered by or carrying bacterial CDase gene. In combination with the negative selection using 5-FC, this positive selection makes it more effective and attractive for using the bacterial CDase in human cancer gene therapy.